Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-GBM Disease”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Very early researchActive Not RecruitingNCT04656535
What this trial is testing

AB154 Combined With AB122 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Yale University 46
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Testing effectiveness (Phase 2)WithdrawnNCT02521090
What this trial is testing

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

Who this might be right for
Adult Brain GlioblastomaAdult GliosarcomaRecurrent Brain Neoplasm
Barbara Ann Karmanos Cancer Institute
Very early researchEnded earlyNCT04825275
What this trial is testing

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 7
Very early researchEnded earlyNCT04869449
What this trial is testing

Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 1
Not applicableStudy completedNCT03664908
What this trial is testing

Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?

Who this might be right for
Lupus Nephritis
CHU de Reims 100
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Testing effectiveness (Phase 2)Looking for participantsNCT04977375
What this trial is testing

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Chirag G. Patil 10
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT03157037
What this trial is testing

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane Antibody Disease
Mårten Segelmark 15
Testing effectiveness (Phase 2)WithdrawnNCT01174537
What this trial is testing

New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma

Who this might be right for
GlioblastomaSarcomaNeuroblastoma
Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT01753713
What this trial is testing

Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Manmeet Ahluwalia, MD 33
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Not applicableStudy completedNCT05894317
What this trial is testing

Vascular Access Complications for Therapeutic Apheresis in Nephrology

Who this might be right for
Vascular Access ComplicationApheresis Related Complication
Central Hospital, Nancy, France 60
Next Page